tiprankstipranks
Trending News
More News >
Restart Life Sciences (TSE:HEAL)
:HEAL
Canadian Market

Restart Life Sciences (HEAL) Financial Statements

Compare
10 Followers

Restart Life Sciences Financial Overview

Restart Life Sciences's market cap is currently C$4.02M. The company's EPS TTM is C$-0.006; its P/E ratio is -2.58; Restart Life Sciences is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 11.47K
Gross ProfitC$ 0.00C$ 25.41KC$ -3.79KC$ -5.00KC$ 1.73K
Operating IncomeC$ -658.51KC$ -1.23MC$ -1.94MC$ -2.93MC$ -1.80M
EBITDAC$ -656.20KC$ -1.20MC$ -1.84MC$ -2.68MC$ -25.23M
Net IncomeC$ 224.75KC$ -1.22MC$ -3.76MC$ -2.68MC$ -25.23M
Balance Sheet
Cash & Short-Term InvestmentsC$ 169.95KC$ 8.09KC$ 266.52KC$ 218.73KC$ 2.14M
Total AssetsC$ 190.40KC$ 31.06KC$ 296.79KC$ 881.16KC$ 3.05M
Total DebtC$ 79.88KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ 68.56KC$ -8.09KC$ -266.52KC$ -218.73KC$ -2.14M
Total LiabilitiesC$ 489.47KC$ 841.66KC$ 255.44KC$ 422.06KC$ 382.96K
Stockholders' EquityC$ -299.07KC$ -810.60KC$ 41.34KC$ 459.10KC$ 2.66M
Cash Flow
Free Cash FlowC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95MC$ -422.11K
Operating Cash FlowC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95MC$ -856.53K
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 29.64KC$ 2.90M
Financing Cash FlowC$ 75.00KC$ 19.10KC$ 1.49MC$ 0.00C$ 0.00
Currency in CAD

Restart Life Sciences Earnings and Revenue History

Restart Life Sciences Debt to Assets

Restart Life Sciences Cash Flow

Restart Life Sciences Forecast EPS vs Actual EPS